
Our History
Major Milestones
Since establishing its U.S. presence, Lupin has recorded steady growth and consolidated its presence in the local market as the third major pharmaceutical company, measured by number of filled prescriptions.
- 2003
- 2004
- 2005
- 2009
- 2010
- 2015
- 2016
- 2017
- 2018
- 2023
- 2024

Lupin Pharmaceuticals Inc. U.S. was formed for commercialization activities in the U.S.
Commences U.S. Branded Business with the launch of Suprax®
Receives US FDA approval for New Lovastatin Plant at Tarapur
- Receives US FDA approval for Goa Finished Dosage facility
- Launches its Generics Business in the U.S.
Acquires the U.S. Rights for Antara®
Becomes the 5th largest generic player in the U.S.
Inaugurates new Center of Excellence for Inhalation Research in Coral Springs, Florida
By acquiring Novel Laboratories, Inc., Lupin created Lupin Somerset, Lupin’s first U.S. based commercial manufacturing facility
- Completes acquisition of U.S. based GAVIS Pharmaceuticals LLC
Acquires Symbiomix Therapeutics, LLC in New Jersey for the launch of Solosec®
- Signs deal with Illinois-based AbbVie offering exclusive rights to develop and commercialize Lupin’s MALT1 inhibitors (oncology)
Solosec® (secnidazole) launched in the U.S.
Lupin launches Tiotropium Dry Powder Inhaler for the treatment of COPD in the United States
- Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to expand access to medication for COPD patients
Lupin Enters the S&P Global Sustainability Yearbook 2024

























Search Product

This website uses cookies to enhance your overall web browsing experience, provide you with ads tailored to your interests, and allow us to measure our audience and collect other analytical data about the use of our website.
By clicking "Accept All" you consent to the collection of your personal information (which may include your Consumer Health Data) through 1st and 3rd party cookies (or similar). To edit your cookie preferences, use the options below.
For more information, please visit our Privacy Statement.
Depending on where you live, you may also be able to exercise your right to opt out or withdraw your consent.Do Not Sell/Share My Personal Information.